Biomerica (BMRA) Net Income towards Common Stockholders (2010 - 2026)
Biomerica (BMRA) posted Net Income towards Common Stockholders of -$1.3 million for Q1 2026, up 0.61% sequentially from -$1.3 million in Q4 2025, and down 12.81% YoY from -$1.5 million in Q1 2025.
Biomerica (BMRA) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Biomerica has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$1.3 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 12.81% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$4.2 million (up 10.47% YoY) and the FY2025 annual result came in at -$5.0 million, up 14.12% from the prior year.
- Net Income towards Common Stockholders grew to -$1.3 million in Q1 2026 per BMRA's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $2000.0 in Q3 2025 and troughed at -$2.3 million in Q2 2023.
- A 5-year average of -$1.3 million and a median of -$1.3 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders tumbled 1483.98% in 2023, then soared 100.15% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$1.6 million in 2022, then climbed by 7.32% to -$1.5 million in 2023, then jumped by 36.96% to -$950000.0 in 2024, then plunged by 38.95% to -$1.3 million in 2025, then advanced by 0.61% to -$1.3 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$1.3 million, -$1.3 million, and $2000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Biomerica | 4.58 Mn | 3.24 Mn | -44,000.00 | -1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1.31 Mn |
| Nov 30, 2025 | -1.32 Mn |
| Aug 31, 2025 | 2,000.00 |
| May 31, 2025 | -1.54 Mn |
| Feb 28, 2025 | -1.16 Mn |
| Nov 30, 2024 | -950,000.00 |
| Aug 31, 2024 | -1.32 Mn |
| May 31, 2024 | -1.23 Mn |
| Feb 29, 2024 | -1.92 Mn |
| Nov 30, 2023 | -1.51 Mn |
| Aug 31, 2023 | -1.13 Mn |
| May 31, 2023 | -2.32 Mn |
| Feb 28, 2023 | -1.65 Mn |
| Nov 30, 2022 | -1.63 Mn |
| Aug 31, 2022 | -2.07 Mn |
| May 31, 2022 | -1.76 Mn |
| Feb 28, 2022 | -104,168.00 |
| Nov 30, 2021 | -1.13 Mn |
| Aug 31, 2021 | -1.54 Mn |
| May 31, 2021 | -3.26 Mn |